Ribosomal protein S6: a potential therapeutic target against cancer?
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …
Selective autophagy of the protein homeostasis machinery: ribophagy, proteaphagy and ER-phagy
CJ Beese, SH Brynjólfsdóttir… - Frontiers in cell and …, 2020 - frontiersin.org
The eukaryotic cell has developed intricate machineries that monitor and maintain proteome
homeostasis in order to ensure cellular functionality. This involves the carefully coordinated …
homeostasis in order to ensure cellular functionality. This involves the carefully coordinated …
Multiscale modeling uncovers 7q11. 23 copy number variation–dependent changes in ribosomal biogenesis and neuronal maturation and excitability
M Mihailovich, PL Germain, R Shyti, D Pozzi… - The Journal of clinical …, 2024 - jci.org
Copy number variation (CNV) at 7q11. 23 causes Williams-Beuren syndrome (WBS) and 7q
microduplication syndrome (7Dup), neurodevelopmental disorders (NDDs) featuring …
microduplication syndrome (7Dup), neurodevelopmental disorders (NDDs) featuring …
Learning critically drives parkinsonian motor deficits through imbalanced striatal pathway recruitment
THC Cheung, Y Ding, X Zhuang… - Proceedings of the …, 2023 - National Acad Sciences
Dopamine (DA) loss in Parkinson's disease (PD) causes debilitating motor deficits.
However, dopamine is also widely linked to reward prediction and learning, and the …
However, dopamine is also widely linked to reward prediction and learning, and the …
Tau drives translational selectivity by interacting with ribosomal proteins
SA Koren, MJ Hamm, SE Meier, BE Weiss… - Acta …, 2019 - Springer
There is a fundamental gap in understanding the consequences of tau–ribosome
interactions. Tau oligomers and filaments hinder protein synthesis in vitro, and they …
interactions. Tau oligomers and filaments hinder protein synthesis in vitro, and they …
Phosphorylation of ribosomal protein S6 differentially affects mRNA translation based on ORF length
J Bohlen, M Roiuk, AA Teleman - Nucleic acids research, 2021 - academic.oup.com
Abstract Phosphorylation of Ribosomal Protein S6 (RPS6) was the first post-translational
modification of the ribosome to be identified and is a commonly-used readout for mTORC1 …
modification of the ribosome to be identified and is a commonly-used readout for mTORC1 …
Proteomics of autism and Alzheimer's mouse models reveal common alterations in mTOR signaling pathway
S Mencer, M Kartawy, F Lendenfeld, H Soluh… - Translational …, 2021 - nature.com
Autism spectrum disorder (ASD) and Alzheimer's disease (AD) are two different neurological
disorders that share common clinical features, such as language impairment, executive …
disorders that share common clinical features, such as language impairment, executive …
IL-17A-mediated excessive autophagy aggravated neuronal ischemic injuries via Src-PP2B-mTOR pathway
T Liu, S Han, Q Dai, J Zheng, C Liu, S Li… - Frontiers in …, 2019 - frontiersin.org
We previously reported that astrocyte-derived proinflammatory cytokine interleukin (IL)-17A
could aggravate neuronal ischemic injuries and strength autophagy both in oxygen-glucose …
could aggravate neuronal ischemic injuries and strength autophagy both in oxygen-glucose …
[HTML][HTML] Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis
Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with
atrophy and fibrosis following skeletal muscle injury. Little is known about the mechanisms …
atrophy and fibrosis following skeletal muscle injury. Little is known about the mechanisms …
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion
Kappa opioid receptor (KOR) agonists produce analgesic and anti-pruritic effects, but their
clinical application was limited by dysphoria and hallucinations. Nalfurafine, a clinically used …
clinical application was limited by dysphoria and hallucinations. Nalfurafine, a clinically used …